Table 3.

Return to hospital visit, second induction modality and delivery (Per Protocol Population).

Outcomes	D24 Dilapan-S 24 hr (N = 96)	D12 Dilapan-S 12 hr (N = 88)	Dilapan-S All (N = 184)	P24 Propess (N = 87)
Bishop score
Return visitb	3 [2,4]	3 [2,5]	3 [2,5]	4 [2,5]
Change from baselineb,c	2 [1,3]	2 [1,3]	2 [1,3]	2 [1,4]
Earlier induction agent removala	12 (13%)	5 (6%)	17 (9%)	39 (45%)
Additional prostaglandin gel needed	68 (71%)	51 (58%)	119 (65%)	30 (34%)
Oxytocin use	74 (77%)	67 (76%)	141 (77%)	61 (70%)
Additional Prostaglandin subgroupd	N = 68	N = 51	N = 119	N = 30
Vaginal delivery rate	48 (71%)	28 (55%)	76 (64%)	16 (53%)
Induction to delivery time (hrs)	49 [44,59]	39 [33,48]	45 [38,56]	52 [48,59]
Bishop scores
Visit 2 (Start of IOL)	1 [0,2]	1 [0,2]	1 [0,2]	1 [0,2]
Visit 3 (Re-assessment visit)	2 [2,3]	2 [1,3]	2 [1,3]	2 [2,3]
Change from Visit 2 to Visit 3	1 [1,2]	1 [0,2]	1 [0,2]	1 [0,2]
No Additional Prostaglandin subgroup	N = 28	N = 37	N = 65	N = 57
Artificial rupture membranes performed	25 (89%)	34 (92%)	59 (91%)	33 (58%)
Vaginal delivery rate	24 (86%)	28 (76%)	52 (80%)	50 (88%)
Induction to delivery time (hrs)	43 [37,52]	30 [26,35]	34 [28,47]	34 [23,43]
Bishop score
Visit 2 (Start of IOL)	2 [1,2]	2 [1,3]	2 [1,3]	1 [1,3]
Visit 3 (Re-assessment visit)	5 [4,7]	5 [4,5]	5 [4,6]	5 [4,7]
Change from Visit 2 to Visit 3	4 [2,5]	3 [2,4]	3 [2,4]	3 [2,5]

Summary statistics are presented as n (%), mean (SD) or median [IQR].

^aRemoval time was missing for 1 patient in the D12 group and 1 patient in the P24 group.

^bBishop score was not recorded at Visit 3 in 5, 5 and 11 patients in the D24, D12 and P24 groups, respectively.

^cOne patient in the D24 group had Bishop score recorded as “<6” at baseline and excluded from the statistical summaries.

^dThe subgroup of patients who required administration of an additional dose of prostaglandin gel (Prostin), after removal of Dilapan-S or Propess.